Telangana

Provis Biolabs Pvt Ltd is a Hyderabad, India based Biotechnology Company founded in the year 2019 to develop, manufacture and market complex biotechnology products through sustainable means. Provis is founded by a team of professionals with over 35 years of combined expertise in biotechnology industry with global experience. Provis has its R&D labs and ISO 9001:2015 and GMP certified manufacturing facilities at Prasanthi nagar, Hyderabad. Provis has commercialized over 4 biotechnology products for therapeutic and bio-manufacturing applications.

Established during the Swadeshi Movement of India, Biological E. Limited (BE) started during a time when the nation sought access to critical healthcare products. Founded and led by Dr. DVK Raju, Biological E. Limited commenced its operations in 1953 as a biological products company manufacturing liver extracts and anti-coagulants.  With an objective of transitioning from treating diseases to preventing them, Biological E.

NIPER-Hyderabad, was set up in 2007 in the erstwhile IDPL R&D centre with the support of CSIR-IICT as the mentor Institute. Ever since its inception, NIPER-Hyderabad has been function- ing with an objective to create an environment congenial for synergizing academia, R&D, and industry, through training and research. Through consistent efforts, it has transformed itself to be a world class institute of teaching and research in Pharmaceutical Sciences and Management.

NIPER-Hyderabad, was set up in 2007 in the erstwhile IDPL R&D centre with the support of CSIR-IICT as the mentor Institute. Ever since its inception, NIPER-Hyderabad has been function- ing with an objective to create an environment congenial for synergizing academia, R&D, and industry, through training and research. Through consistent efforts, it has transformed itself to be a world class institute of teaching and research in Pharmaceutical Sciences and Management.

The U.S. Pharmacopeial Convention (USP) USP is an independent scientific organization that collaborates with the world's top authorities in health and science to develop quality standards for medicines, dietary supplements, and food ingredients. USP's fundamental belief that Equity = Excellence manifests in our core value of Passion for Quality through our more than 1,100 hardworking professionals across five global locations to deliver the mission to strengthen the supply of safe, quality medicines and supplements worldwide.

Shilpa Medicare Limited started its operations as API manufacturer way back in 1987 at Raichur, Karnataka, India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Post: Trainees/Executives, Executive/Sr Executive/Asst Manager, Dy Manager - QC, DRA

Established during the Swadeshi Movement of India, Biological E. Limited (BE) started during a time when the nation sought access to critical healthcare products. Founded and led by Dr. DVK Raju, Biological E. Limited commenced its operations in 1953 as a biological products company manufacturing liver extracts and anti-coagulants.  With an objective of transitioning from treating diseases to preventing them, Biological E.

Maithri Drugs is one of Indias fast-growing pharmaceutical companies. Maithris strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research and development and aggressive growth strategies. Our 39 US DMFs and 14 CEPs in a short span attest to our R&D excellence.

R&D Department

CSIR-Centre for Cellular and Molecular Biology, Hyderabad (CSIR-CCMB) is a premier Research Institute under the aegis of Council of Scientific & Industrial Research (CSIR), an autonomous body under the Ministry of Science & Technology, Government of India. It is a leading research organization in frontier areas of modern biology and involved in conducting high quality basic research and training in multidisciplinary areas of modern biology and to seeking potential applications of the work.